biomarin
BioMarin is a global biotechnology company focused on developing medicines for genetic conditions, emphasizing innovative science and a strong pipeline of drug candidates. The company supports drug discovery and manufacturing for clinical and commercial use, fostering an environment of scientific excellence and problem-solving.
Headquarters
San Rafael, California, United States
Company Size
1001-5000 employees
Founded
1997
BioMarin Pharmaceutical is a global biotechnology company that researches, develops, and commercializes therapies for rare genetic and lysosomal storage diseases. The company has brought medicines to market for conditions such as achondroplasia and severe hemophilia A and focuses on innovative modalities—including gene therapies and biologics—to address high unmet medical needs. BioMarin partners with clinicians, regulators, and patient communities to advance treatments from discovery through global regulatory approval and patient access.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for biomarin.
21% above the average for this role
Associate Director, Quality Control
Nuvalent, Inc.
Automation & MES Engineer Intern
ElevateBio
Automation Engineer II (Hopewell, NJ)
BeOne Medicines
Digital Manufacturing Operations Director
Merck & Co., Inc.
Engineer - Automation Engineering – Small Molecule API- Lilly Medicine Foundry
Eli Lilly and Company
Specialist , Manufacturing Automation
MSD